The nation is in the grip of a tragic opioid crisis, and drugs that are meant for hospital patients are finding their way into other hands. Controlled substance diversion in hospitals is one culprit that is receiving increasing scrutiny. Quartz recently took a look at ways that hospitals can combat diversion among providers, including the role that technology can play. … Read More
Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of a new feature to its Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Bluesight for Controlled Substances’ Investigation Portfolios tool was designed … Read More
ASHP Mid-Year kicks off on Sunday. As the biggest hospital pharmacy event of the year, it is always a great opportunity to learn about the latest trends and technologies and catch up with old friends. As usual, we have lots of new innovations and success stories to share so be sure to work these key activities into your itinerary.
Each year, Kit Check surveys pharmacy leaders across the country about the challenges they face and best practices employed for controlled substances. Our annual Anesthesia Medication Tracking Survey tracks technology adoption, policy changes, and worries in and around the OR. This year, we asked respondents the simple open-ended question, “What is your biggest challenge in and around the OR?” Audit … Read More
As the national conversation around opioid abuse continues to grow, hospitals grappling with citations, fines and the bad publicity that accompany these events are looking for solutions that can have both an immediate reduction in liability and set them up for long-term compliance and risk abatement.
As the opioid epidemic continues to make headlines, hospitals are facing increasing pressure to detect and prevent controlled substance diversion. In response, the American Society of Health-System Pharmacists (ASHP) released guidelines on developing a comprehensive diversion prevention program which builds upon similar publications by the CDC, DEA and The Joint Commission. Given the risks, hospitals should heed these guidelines to ensure they have the safeguards in place to avoid similar incidents that have plagued the headlines.